Researcher Spotlight: Dr. Tess Eidem

Dr. Tess Eidem, a bioaerosol scientist and biochemist, is a key voice to be amplified when discussing cannabis patient, consumer, and worker safety.

She believes that “Cannabis is a growing industry with a growing workforce, and those workers deserve to know what they're breathing. My lab studies the airborne allergens, molds, and other bioaerosols in cannabis facilities, so that we can give workers, employers, and regulators the practical tools they need to keep workers safe."

Dr. Eidem began her higher education journey at the University of Nebraska, Omaha where she completed her Bachelor of Science degree in Biology. She then went on to obtain a Ph.D. in Microbiology from the University of Nebraska Medical Center in 2013 (ICR, 2023). She was also a recipient of the ElSohly Award in 2025. Through various occupational positions, Dr. Eidem has worked in cannabis industry leadership roles across three different countries striving to learn more about the occupational exposures that exist within the industry (Eidem Lab, 2026). She has dedicated herself and her work to identifying antimicrobial compounds that are effective against these harmful bioaerosol pathogens, allergens, and toxins. 

Her current research, being conducted in her own lab at the University of Colorado, Boulder, studies the numerous dangerous bioaerosols that are present and being inhaled by workers in cannabis cultivation and processing facilities. How these compounds can affect the employed individuals and how to mitigate and minimize this exposure is just one of the many benefits Dr. Eidem’s lab is working to provide for the cannabis industry. Dr. Eidem’s work is inherently important to the safety and continuation of the field as a whole as there are growing numbers of reported incidents of individuals falling ill, typically with respiratory illnesses, due to extended microbial inhalation in these facilities (Eidem et al., 2024).

To further explain the work of Dr. Eidem and her team, we have included a breakdown regarding bioaerosols. This section identifies what they are and where they come from, while also summarizing the goal of Dr. Eidem’s lab, mitigating these exposures. 

What is a bioaerosol?

According to Dr. Eidem et al., 2024, a bioaerosol is defined as “an airborne particulate matter compromised in whole or in part of primary biological materials,” (Eidem et al., 2024). This means that any biologically originating particulate that exists in the air is defined as a bioaerosol. Bioaerosols are prominent in cannabis facilities and can be found in many different forms such as mold, fungus, pollen, and ground plant material dust. Given that cannabis manufacturing processes must be completed in well ventilated areas, particles are constantly being lifted and distributed through air circulation systems, typically with inefficient filtration systems. These unseen particles can cause respiratory issues, and even damage, especially in individuals who may be more prone to respiratory distress, such as individuals with pre-existing asthma. Discovering an antimicrobial agent to decrease or even completely eradicate the presence of these bioaerosols in cannabis production facilities is the main goal of Dr. Eidem and her team. 

In her current work, "Uncovering the Risks: An Urgent Need to Investigate the Occupational Respiratory Hazards in the Growing Cannabis Industry," funded by NIH R01 in August of 2026, Dr. Eidem and her lab are utilizing their combined array of gained expertise to understand these exposures and how to protect cannabis industry workers (Eidem Lab, 2026). Having an accessible resource regarding the potential bioaerosol hazards that exist within cannabis processing and cultivation facilities is essential to provide for the protection for all cannabis workers. 

Resources: 

Eidem, T., Nordgren, T., & Hernandez, M. (2024). Bioaerosol Exposures and Respiratory Diseases in Cannabis Workers. Current allergy and asthma reports, 24(7), 395–406. https://doi.org/10.1007/s11882-024-01157-7

Research—Tess Eidem, PhD. (2026). Eidem Lab. Retrieved September 27, 2026, from https://eidemlab.com/research

Tess Eidom PhD, PCQI, Assessing and Addressing Microbial Risks to Cannabis Patients and Consumers. (October 2023). Institute of Cannabis Research (ICR). https://www.instituteofcannabisresearchcolorado.org/webinars/tess-eidom-assessing-and-addressing-microbial-risks/

Next
Next

Introducing the Resource Center for Cannabis and Cannabinoid Research (R3CR)